ARCH Venture Management, LLC Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$492.4B
Holdings
9
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (9 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RAPPRAPPORT THERAPEUTICS INC. | 3,728,738 | $110.7B | 22.49% | |
| 2 | BEAMBEAM THERAPEUTICS INC. | 4,540,132 | $110.2B | 22.38% | |
| 3 | MAZEMAZE THERAPEUTICS INC. | 4,120,053 | $106.8B | 21.70% | |
| 4 | VIRVIR BIOTECHNOLOGY INC. | 12,916,663 | $73.8B | 14.98% | |
| 5 | LYELLYELL IMMUNOPHARMA INC. | 2,759,072 | $44.8B | 9.10% | |
| 6 | ERASERASCA INC. | 11,055,554 | $24.1B | 4.89% | |
| 7 | GOSSGOSSAMER BIO INC. | 8,055,916 | $21.2B | 4.30% | |
| 8 | QTTBQ32 BIO INC. | 320,482 | $634.6M | 0.13% | |
| 9 | CEROCERO THERAPEUTICS HOLDINGS INC. | 22,389 | $114.0M | 0.02% |